Skip to content
Scintria
ToolsGrant writerFunding
HomeLiteratureClinical trialsEvidence LabProtocol packData analysisLearnProjectsLibraryReferencesApplications
Start free
ScintriaStart free

Learn / Clinical Research Management / Foundations: ethics, GCP and the drug development pathway

The ethical foundations of clinical research

13 minute read · 6-question quiz

Download this lesson as a colour Word or PDF study guide with the figures and answers. Included in paid plans; reading and quizzes stay free.Sign in

What you will learn

  • Trace the history that produced modern research ethics, from the Nuremberg Code to the Belmont Report

  • State the principles of the Declaration of Helsinki and the Belmont Report

  • Apply the principles to judge whether a study design is acceptable

Clinical research asks people to accept risk so that others, and sometimes they themselves, may benefit. The rules that govern it were written in response to serious abuses. Knowing that history explains why every protocol, consent form and monitoring visit exists.

Milestones

  • 1947, the Nuremberg Code: written after the trial of physicians who conducted cruel experiments in Nazi camps. Its first principle is that voluntary consent is absolutely essential.
  • 1964, the Declaration of Helsinki (World Medical Association): ethical principles for medical research involving human subjects. It has been revised several times. It stresses that the welfare of the participant takes precedence over the interests of science and society, requires independent ethics review, and sets rules for placebo use and post-trial access.
  • 1972, the Tuskegee disclosure and 1979, the Belmont Report: public exposure of the US Public Health Service study in which Black men with syphilis were observed without treatment, even after penicillin became available, led to the Belmont Report.
  • 1982 onwards, CIOMS guidelines: the Council for International Organizations of Medical Sciences adapted the principles for international and resource-limited settings. The current guidelines were published in 2016.
  • 1996 onwards, ICH-GCP: a harmonised standard for the design, conduct, recording and reporting of trials.

The three Belmont principles

  • Respect for persons: people are autonomous and must give informed, voluntary consent; those with reduced autonomy (children, people with cognitive impairment, prisoners) are entitled to extra protection.
  • Beneficence: do no harm, maximise possible benefits and minimise possible harms.
  • Justice: fairly distribute the burdens and benefits of research. Vulnerable groups should not carry the risk while others enjoy the benefit.
1947Nuremberg Code1964Declaration ofHelsinki1979Belmont Report2016CIOMS guidelines; ICHE6(R2)
Four landmarks. Each followed a failure that taught the research community something.

What the principles require in practice

  • Informed consent that is understood, voluntary and documented.
  • Independent review of the protocol by a research ethics committee (REC) before the study starts and during its conduct.
  • A favourable risk-benefit balance, with risks minimised and justified by the scientific value.
  • Scientific validity: a poorly designed study cannot be ethical because it exposes people to risk without the chance of a useful answer.
  • Fair selection of participants, and attention to vulnerability.
  • Confidentiality of personal data.
  • Care and compensation for study-related injury.
  • Community engagement and, where appropriate, post-trial access to proven benefits.

Worked example: is this study acceptable?

A sponsor proposes testing a new anti-malarial in a rural district. The draft protocol enrols patients at a clinic, using a verbal explanation and a thumbprint where the person cannot read. The comparator is no treatment.

  • Consent: acceptable only if the explanation is in the local language, uses an impartial witness where the participant cannot read, and the participant has time to ask questions.
  • Comparator: giving no treatment to a person with malaria when effective treatment exists is not acceptable. The control group must receive the standard of care.
  • Justice: the district must stand to benefit from the findings, for example through access to the medicine if it proves effective.

An ethics committee would require changes on both counts before approval.

Respect forpersonsBeneficenceJusticeEthical research
The three Belmont principles. A study must satisfy all three.

Ethics is built in, not added on

Ethics shapes the design: the question, the comparator, who is enrolled, how consent is obtained and how safety is watched. It is not a signature added at the end.

Compliance is not the same as ethics

A study can follow every regulation and still treat participants badly, for example by rushing consent or ignoring concerns. Aim at the spirit of the principles, not only the checklist.

Check yourself

Take any protocol you know. Find where it protects each of respect for persons, beneficence and justice. If one is hard to find, raise it with the team.

Summary

  • Modern research ethics grew from abuses: Nuremberg (1947), Helsinki (1964) and Belmont (1979).

  • The Belmont principles are respect for persons, beneficence and justice.

  • Independent ethics review, informed consent and a favourable risk-benefit balance are essential.

  • A scientifically weak study is unethical because it exposes participants to risk without useful results.

Check your understanding

Question 1
1

The first principle of the Nuremberg Code is that:

Question 2
2

Which document lists respect for persons, beneficence and justice?

Question 3
3

The Declaration of Helsinki is issued by the:

Question 4
4

Withholding effective treatment from a control group with malaria is:

Question 5
5

An 'impartial witness' is needed when:

Question 6
6

Why can a poorly designed study be unethical?

Draft study guide. Spotted an error or something unclear? Tell us at hello@scintria.com. This is educational material, not clinical or regulatory advice.

ICH-GCP: the principles and the people